CASE REPORT
===========

We describe the case of an 81-year-old Caucasian woman who was referred to our hospital with swelling of the neck and upper left limb and a 2-week history of dysphonia and dysphagia, associated with an involuntary weight loss of 16 kg over the previous 2 months. Ten months earlier she had been diagnosed with ascending colon adenocarcinoma stage IIIb without distant metastatic disease (T4aN1b.IVL), and underwent right hemicolectomy. She was not eligible for adjuvant chemotherapy as she had stage 3 chronic kidney disease and ischaemic cardiomyopathy. On physical examination, she had face and neck oedema with visible collateral veins. She had three abdominal non-painful subcutaneous nodules, but no further relevant abnormalities.

Laboratory tests showed anaemia (haemoglobin 10.5 g/dl; normal range 12.0--16.0 g/dl), a normal serum carcinoembryonic antigen (CEA, 5 ng/ml; normal range 0--5 ng/dl) and elevated cancer antigen 19-9 (57 U/ml; normal range \<37 U/ml). A chest x-ray revealed enlargement of the mediastinum ([Fig. 1](#f1-1115-1-7921-1-10-20190513){ref-type="fig"}).

Therefore, upper endoscopy was performed and revealed an extrinsic compression area of approximately 4 cm (18--22 cm from the incisor teeth); no other changes were observed. An abdominal ultrasound only revealed three well-defined hypoechogenic subcutaneous nodules that could have been tumour implants. Computed tomography (CT) scans of the chest, abdomen and pelvis showed a large bulky solid tumoral lesion with heterogeneous density, measuring 9.0 cm at its greatest diameter, in the posterior mediastinum with invasion of the first two dorsal vertebral bodies, as well as of the supra-aortic trunks, close to the posterior wall of the trachea. It had invaded the oesophagus and the pleural space bilaterally ([Figs. 2](#f2-1115-1-7921-1-10-20190513){ref-type="fig"}[](#f3-1115-1-7921-1-10-20190513){ref-type="fig"}--[4](#f4-1115-1-7921-1-10-20190513){ref-type="fig"}).

Several cutaneous nodules on the abdomen compatible with metastases were found ([Fig. 5](#f5-1115-1-7921-1-10-20190513){ref-type="fig"}). No metastases or other pathologies were identified in the lungs, and abdominal-pelvic CT images were unremarkable. CT-guided fine needle aspiration cytology of the mediastinal tumour and the subcutaneous nodules was compatible with metastatic adenocarcinoma. Immunohistochemical staining of the core biopsy samples was negative for cytokeratin 7 (CK7) and neuroendocrine markers, and positive for cytokeratin (CK) AE1/AE3, CDX2, CAM 5.2 and CK20, which is typical of colorectal primary carcinoma.

DISCUSSION
==========

This report describes a case of SVC syndrome that resulted from external compression by a metastatic mediastinal mass from colorectal cancer. This is a rare cause of SVC syndrome and itself an unexpected and rare metastasis. Over 80% of cases of SVC syndrome are due to malignancy, but generally from lung cancer or lymphoma^\[[@b1-1115-1-7921-1-10-20190513]\]^. Another uncommon finding in this case was the aetiology of the mediastinal mass, as the majority of lesions in the posterior mediastinum are lymphadenopathies, neurogenic tumours or cystic lesions. In addition, mediastinal lymph node metastases are rare in colorectal cancer, especially when there are no lung or liver metastases. A further peculiarity was the subcutaneous nodules, which are found only in 4--6.5% of metastatic colon adenocarcinoma cases^\[[@b2-1115-1-7921-1-10-20190513]\]^. As in our patient, the most common site is the abdominal skin and they are frequently related to poor prognosis.

Only 12 cases of mediastinal metastasis from colorectal cancer have been reported in the English literature ([Table 1](#t1-1115-1-7921-1-10-20190513){ref-type="table"})^\[[@b3-1115-1-7921-1-10-20190513]--[@b13-1115-1-7921-1-10-20190513]\]^. However, this is the first reported case of a bulky isolated mediastinal mass with an exuberant presentation such a short time after primary tumour resection. In the majority of cases, the primary tumour was located on the ascending colon (41.6%) and 83.3% of patients were men. Although mediastinal metastasis is frequently related to liver or lung metastasis, only six cases presented with liver metastasis. Direct colon metastasis to the mediastinal lymph nodes was described in eight case reports. In nine cases, the mediastinal lymph node metastasis appeared more than 1 year after resection of the primary cancer. In one case, the metastasis led to the diagnosis of colorectal carcinoma as the primary cancer.

The pathway of this metastasis is unclear, but there are two possible routes: retrograde lymph node and haematogenous spread ^\[[@b14-1115-1-7921-1-10-20190513]\]^. Kuba et al. proposed that the tumour cells from ovarian metastasis spread through the paravertebral venous plexus (remetastasis or metastasis of metastasis) or the para-aortic lymphatic drainage route^\[[@b4-1115-1-7921-1-10-20190513]\]^. Remetastasis of colon cancer to the mediastinal lymph nodes was also described from the lungs and liver. Vetto et al. reported a case of colon cancer metastasizing to the right lobe of the liver with an isolated mediastinal lymph node metastasis. The authors' hypothesis was that the lymphatics from the falciform ligament and right lateral lobe drained upwards through the diaphragm, caval foramen and oesophageal hiatus to the mediastinal nodes^\[[@b3-1115-1-7921-1-10-20190513]\]^. In fact, many cases of gastrointestinal cancer metastasize via the thoracic duct from a retroperitoneal lymph node (via retrograde lymph node metastasis). This may occur through incompetent valves of lymphatics as there is no communication between the thoracic duct and the bronchomediastinal trunk^\[[@b15-1115-1-7921-1-10-20190513]\]^.

The diagnosis of a mediastinal mass is challenging as many of these masses have a similar appearance on imaging, varying only in certain details seen on CT. The location and composition of a mass together with the clinical history can lead to the diagnosis. In our case, despite expectations, the pathological diagnosis was conclusive and showed colon cancer metastasis^\[[@b16-1115-1-7921-1-10-20190513]\]^. The benefits of adjuvant chemotherapy are still uncertain, as is the role of radiotherapy in these patients. Surgery has been reported as a treatment for solitary lymph node metastasis, with a good prognosis. However, the efficacy of mediastinal metastasectomy is unproven because not enough cases have been described in the literature to support it. As mediastinal metastases of colon cancer are rare, the treatment strategy has yet to be established^\[[@b17-1115-1-7921-1-10-20190513]\]^. Although there are few reported cases of mediastinal metastasis from colorectal cancer, physicians should be aware of these less common locations and consider the possibility of mediastinal lymph node metastasis as a differential diagnosis. Patients should have a close follow-up in order to avoid the development of unresectable metastases, since surgery, when applicable, can lead to a better prognosis.
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###### 

Cases of mediastinal metastasis from colorectal cancer reported in the English literature

  Case number   Reference                                                         Year published   Age    Sex   Primary location             Primary stage   Adjuvant chemotherapy                                          Time after Primary resection(months)   Metastasis location
  ------------- ----------------------------------------------------------------- ---------------- ------ ----- ---------------------------- --------------- -------------------------------------------------------------- -------------------------------------- ---------------------------------
  *1*           *Vetto et al.* ^\[[@b3-1115-1-7921-1-10-20190513]\]^              *1991*           *60*   *M*   *Hepatic flexure*            *IIIb*          *Not listed*                                                   *12*                                   *Right lobe liver, mediastinum*
  *2*           *Kuba et al.* ^\[[@b4-1115-1-7921-1-10-20190513]\]^               *1999*           *60*   *F*   *Sigmoid*                    *IIIb*          *Not listed*                                                   *33*                                   *Left ovary, mediastinum*
  *3*           *Musullam et al.* ^\[[@b5-1115-1-7921-1-10-20190513]\]^           *2008*           *67*   *M*   *Rectosigmoid*               *IIIb*          *Yes*                                                          *26*                                   *Mediastinum*
  *4*           *Yavaş et al.* ^\[[@b6-1115-1-7921-1-10-20190513]\]^              *2009*           *57*   *M*   *Ascending*                  *IIIa*          *5-Fluorouracil*                                               *Not listed*                           *Mediastinum*
  *5*           *Sano et al.* ^\[[@b7-1115-1-7921-1-10-20190513]\]^               *2011*           *29*   *M*   *Ascending*                  *IVa*           *5-Fluorouracil*                                               *24*                                   *Liver, mediastinum*
  *6*           *Iwata et al.* ^\[[@b8-1115-1-7921-1-10-20190513]\]^              *2012*           *75*   *M*   *Ascending and transverse*   *IIIa*          *Capecitabine*                                                 *42*                                   *Liver, mediastinum*
  *7*           *Matsuda et al.*^\[[@b9-1115-1-7921-1-10-20190513]\]^             *2014*           *65*   *M*   *Sigmoid*                    *IIIc*          *Tegafur-uracil*                                               *101*                                  *Mediastinum*
  *8*           *Matsuda et al.*^\[[@b9-1115-1-7921-1-10-20190513]\]^             *2014*           *50*   *M*   *Rectum*                     *IIIc*          *No*                                                           *96*                                   *Mediastinum*
  *9*           *Halabi et al.* ^\[[@b10-1115-1-7921-1-10-20190513]\]^            *2014*           *44*   *M*   *Ascending*                  *IIIa*          *Folinic acid, fluorouracil, oxaliplatin, bevacizumab*         *22*                                   *Mediastinum*
  *10*          *Shirakawa et al.* ^\[[@b11-1115-1-7921-1-10-20190513]\]^         *2015*           *65*   *M*   *Rectum*                     *IIIa*          *Tegafur-uracil, 5-fluorouracil, leucovorin and oxaliplatin*   *55*                                   *Liver, mediastinum*
  *11*          *Rodríguez-López et al.* ^\[[@b12-1115-1-7921-1-10-20190513]\]^   *2016*           *45*   *M*   *Rectum*                     *IVa*           *Folinic acid fluorouracil and oxaliplatin, bevacizumab*       *--*                                   *Mediastinum*
  *12*          *Toda et al.*^\[[@b13-1115-1-7921-1-10-20190513]\]^               *2017*           *59*   *M*   *Ascending*                  *IIIb*          *Yes*                                                          *32*                                   *Mediastinum*
